CROI 2017 Program and Information

Program and Agenda

Symposium S-7 GETTING TO THE THIRD 90 Room 6 C 4:00 PM - 6:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in understanding progress and challenges in maximizing the percentage of people on antiretroviral therapy who have viral load suppression, particularly in low and middle income settings, and how global targets for viral suppression can be achieved in the future. Level of Knowledge: It is assumed that the participants are familiar with effects of antiretroviral treatment on HIV viral load, the basic concepts of viral load measurement, and the influences of adherence and drug resistance. Objectives: At the completion of the session, participants will be able to: • Describe the issues related to implementation of monitoring of ART in low and middle income settings • Describe challenges in achieving the target of 90% virally suppressed Conveners Laura Broyles , Centers for Disease Control and Prevention, Atlanta, GA, USA Velephi Okello , Swaziland Ministry of Health, Mbabane, Swaziland 104 ACTING OR NOT ACTING ONVIRAL LOAD Steven J. Reynolds , NIAID , NIH, Washington, DC, USA 4:00

105 MEASURING VIRAL LOAD: INNOVATIONS AND TAKING TO SCALE Rosanna W. Peeling , London Sch of Hygiene and Trop Medicine, London, United Kingdom 106 USING TECHNOLOGY TO IMPROVE ADHERENCE Richard T. Lester , Univ of British Columbia, Vancouver, Canada 107 REACHING KEY ANDVULNERABLE POPULATIONS TO ACHIEVE THE THIRD 90 Ruanne V. Barnabas , Univ of Washington, Seattle, USA 4:30 5:00 5:30

Oral Sessions • Wednesday

CROI 2017 59